Clinical Trials
3 trialsNCT01418677 2016-05-17
An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function
Eisai Inc.
Phase 1 Completed
NCT00415324 2014-05-20
Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00047034 2013-01-07
E7389 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed